The Food and Drug Administration (FDA) carried out an inspection at Schell & Kampeter, Inc. in Frontenac on April 21 to review operations involving marketed animal drugs, feed, and devices, according to data posted on the FDA’s website.
The final report found that Schell & Kampeter, Inc. was not required to make any changes to its management practices.
The FDA regularly inspects locations nationwide, assessing whether workplaces and products meet regulatory requirements established to protect public health. After inspections, results are made publicly available.
According to its website, the FDA is a federal agency that oversees the safety and quality of human and animal drugs, biological products, medical devices and tobacco products throughout their production and distribution.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
